Aktas BY - Search Results

1

Complete responses to two different anti-PD1 agents in a metastatic melanoma patient.

Kilickap S, Guven DC, Aktepe OH, Aktas BY, Dizdar O. Kilickap S, et al. Among authors: aktas by. J Oncol Pharm Pract. 2020 Mar;26(2):496-499. doi: 10.1177/1078155219858657. Epub 2019 Jun 29. J Oncol Pharm Pract. 2020. PMID: 31256744

2

Noninferiority for Short-HER or short-chemotherapy?

Aktas BY, Guven DC, Dizdar O. Aktas BY, et al. Ann Oncol. 2019 Jan 1;30(1):147. doi: 10.1093/annonc/mdy491. Ann Oncol. 2019. PMID: 30395162 Free article. No abstract available.

3

Exploiting DNA repair defects in breast cancer: from chemotherapy to immunotherapy.

Aktas BY, Guner G, Guven DC, Arslan C, Dizdar O. Aktas BY, et al. Expert Rev Anticancer Ther. 2019 Jul;19(7):589-601. doi: 10.1080/14737140.2019.1631162. Epub 2019 Jun 17. Expert Rev Anticancer Ther. 2019. PMID: 31181965 Review.

4

Evaluation of cancer risk in patients with periodontal diseases.

Güven DC, Dizdar Ö, Akman AC, Berker E, Yekedüz E, Ceylan F, Başpınar B, Akbıyık İ, Aktaş BY, Yüce D, Erman M, Hayran M. Güven DC, et al. Among authors: aktas by. Turk J Med Sci. 2019 Jun 18;49(3):826-831. doi: 10.3906/sag-1812-8. Turk J Med Sci. 2019. PMID: 31195790 Free PMC article.

5

Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications.

Guven DC, Aktas BY, Simsek C, Aksoy S. Guven DC, et al. Among authors: aktas by. Future Oncol. 2020 Mar;16(9):497-506. doi: 10.2217/fon-2019-0783. Epub 2020 Feb 26. Future Oncol. 2020. PMID: 32100550 Review.

6

Defining the Optimal Regimen for Stage III Colon Cancer: Concerns with Study Design.

Guven DC, Guner G, Aktas BY, Aktepe OH, Taban H, Arik Z. Guven DC, et al. Among authors: aktas by. Clin Colorectal Cancer. 2020 Sep;19(3):e71-e72. doi: 10.1016/j.clcc.2020.02.011. Epub 2020 Mar 6. Clin Colorectal Cancer. 2020. PMID: 32224043 No abstract available.

7

Cancer incidence in Behçet's disease.

Guven DC, Bolek EC, Altintop SE, Celikten B, Aktas BY, Kiraz S, Gullu İ, Karadag O, Dizdar O. Guven DC, et al. Among authors: aktas by. Ir J Med Sci. 2020 Nov;189(4):1209-1214. doi: 10.1007/s11845-020-02244-0. Epub 2020 May 8. Ir J Med Sci. 2020. PMID: 32383138

8

COVID-19 pandemic: changes in cancer admissions.

Guven DC, Aktas BY, Aksun MS, Ucgul E, Sahin TK, Yildirim HC, Guner G, Kertmen N, Dizdar O, Kilickap S, Aksoy S, Yalcin S, Turker A, Uckun FM, Arik Z. Guven DC, et al. Among authors: aktas by. BMJ Support Palliat Care. 2020 Jul 14:bmjspcare-2020-002468. doi: 10.1136/bmjspcare-2020-002468. Online ahead of print. BMJ Support Palliat Care. 2020. PMID: 32665259

9

Case of metastatic kaposi sarcoma successfully treated with anti-PD-1 immunotherapy.

Cesmeci E, Guven DC, Aktas BY, Aksoy S. Cesmeci E, et al. Among authors: aktas by. J Oncol Pharm Pract. 2021 Oct;27(7):1766-1769. doi: 10.1177/1078155220985589. Epub 2021 Jan 11. J Oncol Pharm Pract. 2021. PMID: 33427037

10

Pazopanib-induced chylothorax in a patient with renal cell carcinoma.

Koylu B, Tekin F, Aktas BY, Kilickap S, Koksal D. Koylu B, et al. Among authors: aktas by. Anticancer Drugs. 2022 Jan 1;33(1):e555-e557. doi: 10.1097/CAD.0000000000001172. Anticancer Drugs. 2022. PMID: 34387587

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters